Nils W Engel Selected Research

Nils W Engel Research Topics

4	Neoplasms (Cancer) 05/2024 - 01/2019
2	Lymphoma (Lymphomas) 05/2024 - 01/2022
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Body Weight (Weight, Body) 01/2022
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2022
1	Leukemia 01/2022
1	Fanconi Anemia (Fanconi's Anemia) 01/2019
1	Fever (Fevers) 01/2019
1	Bone Marrow Failure Disorders 01/2019
1	Genomic Instability 01/2019
1	Cholangiocarcinoma 01/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2016

2	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2022
1	Interleukin-18 (Interleukin 18)IBA 05/2024
1	Adenine FDA LinkGeneric 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	EpitopesIBA 01/2023
1	AntigensIBA 01/2023
1	CX-PlusIBA 01/2022
1	plerixafor FDA Link 01/2022
1	B-Cell Maturation AntigenIBA 01/2022
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2022
1	PlatinumIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Gemcitabine FDA Link 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	ponatinibIBA 01/2016

2	Therapeutics 05/2024 - 01/2023
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2019
1	Immunotherapy 01/2023
1	Hematopoietic Stem Cell Mobilization 01/2022